7 Best Stocks for the Next 30 Days

Get them in a free Special Report, and get more Zacks Insights in our free e-newsletter, Profit from the Pros. Every issue includes a fresh Zacks #1 Bull Stock of the Day.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/21/2013

Company Name Symbol %Change
SCIENTIFIC L SCIL
8.00%
NATUS MEDICA BABY
6.11%
SUMMER INFAN SUMR
6.02%
RADIANT LOGI RLGT
5.32%
NEW ORIENTAL EDU
4.51%

Cullen/Frost Prices Preferred Stock

by Zacks Equity Research

February 13, 2013 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

On Tuesday, Cullen/Frost Bankers, Inc. ( CFR - Snapshot Report ) announced the pricing of a public offering of non-cumulative perpetual preferred stock worth approximately $150 million. The offering is expected to close on Feb 15, 2013, subject to customary closing conditions. The liquidation amount is set to be $25 per share.

The offering includes 6,000,000 shares of the company’s non-cumulative perpetual preferred stock, Series A, which qualifies as Tier 1 capital and carries a coupon rate of 5.375%. The joint-book running managers for the offering are Morgan Stanley ( MS - Analyst Report ) , Goldman Sachs ( GS - Analyst Report ) and UBS Investment Bank, a unit of UBS AG ( UBS - Analyst Report ) .
The proceeds from the issuance and sale of the preferred stock are expected to be roughly $144.5 million (after subtracting underwriting discount and commissions, as well as the payment of estimated expenses).
The company plans to use the proceeds to repurchase its common shares. This is in accordance to the terms of the company’s accelerated share repurchase agreement with Goldman Sachs. Under the terms of the deal, Cullen/Frost will pay $144.0 million to Goldman Sachs on Feb 15, 2013 and will receive common shares in exchange.
A sizeable amount of the shares are anticipated to be delivered on Feb 15, with the remaining amount expected upon completion of the program. However, the total number of shares that Cullen/Frost will obtain and the total amount paid will depend on the volume-weighted daily average price of Cullen/Frost’s common share during the tenure of the repurchase program.
Cullen/Frost currently retains a Zacks Rank #3 (Hold).

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.